Skip to content

A2 GUM Post-Market Effectiveness Study

Real-World Effectiveness Study of A2 Growing Up Milk (GUM) Among Young and Pre-School Age Toddlers in China

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03698058
Enrollment
387
Registered
2018-10-05
Start date
2018-09-15
Completion date
2019-03-31
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Intolerance

Keywords

Nutrition, Toddlers, A2, B-casein, Gut comfort, Growing up milk

Brief summary

This is a post-market, real-life effectiveness study of A2 growing up milk on toddlers' gut comfort.

Detailed description

This post-market study primarily aims to assess the real-life effectiveness of a newly-launched A2 milk on toddlers' gut comfort via evaluating individual GI symptoms and GI-related behaviors compared with other milk products and milk alternatives.

Interventions

DIETARY_SUPPLEMENTToddler milk

Commercially available toddler milk

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Months to 36 Months
Healthy volunteers
Yes

Inclusion criteria

* Having obtained his / her parents' (or his or her legally accepted guardian written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parent(s) / legal guardian has been informed of all pertinent aspects of the study. * Children 12 - 36 months of age at enrolment. * Children who have been born full-term (≥ 37 completed weeks of gestation) and having a birth weight ≥ 2.5 kg and ≤ 4.5 kg. * Children who are habitually consuming some cow's milk, other traditional milks (including non-A2 GUMs, kids' milk, white milk, flavored milk) and/or dairy or non-dairy alternative milks (such as those sourced from goats, sheep, soy, rice, coconut, and nut). * Child's parent(s) / guardian is of legal age of consent, has sufficient command of Chinese (Mandarin) language to complete the informed consent and other study documents, is willing and able to fulfill the requirements of the study protocol.

Exclusion criteria

* Chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or may impact outcome measures. * Known and diagnosed cow's milk protein allergy. * Children currently using or having ever used specialty infant formula and/or GUMs such as hypoallergenic (HA), lactose-free, or anti-regurgitation formulas. * Children who have known cognitive and developmental disorders.

Design outcomes

Primary

MeasureTime frameDescription
Overall digestive comfortBaseline to Study Day 14Toddler Gut Comfort score from parent-reported questionnaire (sub-scale range from 1 to 6, 10 sub-scales, total scores range from 10-60).

Secondary

MeasureTime frameDescription
Stool consistencyBaseline, Study Day 7, Study Day 14Stool consistency score reported by parents in 3-Day GI Symptoms Diary
Consumption of other milk productsBaseline, Study Day 7, Study Day 14Reported by parents on 3 consecutive days on Milk Intake Diary
Child weightBaseline, Study Day 7, Study Day 14Weight as measured by study staff in health clinic
Stool frequencyBaseline, Study Day 7, Study Day 14Stool frequency reported by parents in 3-Day GI Symptoms Diary
Child head circumferenceBaseline, Study Day 7, Study Day 14Head circumference as measured by study staff in health clinic
Adverse eventsBaseline to Study Day 14All adverse events reported by parents and confirmed by study investigator
Child heightBaseline, Study Day 7, Study Day 14Weight as measured by study staff in health clinic

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026